Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark A Rochester

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
BJU International|June 26, 2004
Genetics for urologistsMark A Rochester, Simon F Brewster
BJU International|June 7, 2014
Nephroureterectomy surgery in the UK in 2012: British Association of Urological Surgeons (BAUS) Registry dataStephen S Connolly, Mark A Rochester,
The Journal of Urology|January 12, 2005
A double-blind, randomized, controlled trial of topical glyceryl trinitrate for transrectal ultrasound guided prostate biopsyMark A Rochester, Karena LE Monnier, Simon F Brewster
Annals of the Royal College of Surgeons of England|February 18, 2009
A randomised trial of conventional versus BAUS procedure-specific consent forms for transurethral resection of prostateWilliam J G Finch, Mark A Rochester, Robert D Mills
BMC Urology|July 18, 2009
Development and validation of risk score for predicting positive repeat prostate biopsy in patients with a previous negative biopsy in a UK populationMark A Rochester, Nora Pashayan, Fiona Matthews, et al.
Cancer Gene Therapy|October 23, 2004
Silencing of the IGF1R gene enhances sensitivity to DNA-damaging agents in both PTEN wild-type and mutant human prostate cancerMark A Rochester, Johann Riedemann, Giles O Hellawell, et al.
BJU International|July 25, 2007
The type 1 insulin-like growth factor receptor is over-expressed in bladder cancerMark A Rochester, Nilay Patel, Benjamin W Turney, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
BJU International|June 26, 2004
Genetics for urologistsMark A Rochester, Simon F Brewster
BJU International|June 7, 2014
Nephroureterectomy surgery in the UK in 2012: British Association of Urological Surgeons (BAUS) Registry dataStephen S Connolly, Mark A Rochester,
The Journal of Urology|January 12, 2005
A double-blind, randomized, controlled trial of topical glyceryl trinitrate for transrectal ultrasound guided prostate biopsyMark A Rochester, Karena LE Monnier, Simon F Brewster
Annals of the Royal College of Surgeons of England|February 18, 2009
A randomised trial of conventional versus BAUS procedure-specific consent forms for transurethral resection of prostateWilliam J G Finch, Mark A Rochester, Robert D Mills
BMC Urology|July 18, 2009
Development and validation of risk score for predicting positive repeat prostate biopsy in patients with a previous negative biopsy in a UK populationMark A Rochester, Nora Pashayan, Fiona Matthews, et al.
Cancer Gene Therapy|October 23, 2004
Silencing of the IGF1R gene enhances sensitivity to DNA-damaging agents in both PTEN wild-type and mutant human prostate cancerMark A Rochester, Johann Riedemann, Giles O Hellawell, et al.
BJU International|July 25, 2007
The type 1 insulin-like growth factor receptor is over-expressed in bladder cancerMark A Rochester, Nilay Patel, Benjamin W Turney, et al.
Pageof 1